Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for ...

Dr Liz O'Riordan's brilliant new book aims to challenge misinformation about cancer. In an exclusive extract, she tackles ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Approximately 1 in 5 people develop cancer in their lifetime, and it continues to be one of the leading causes of mortality ...

Science Breast cancer, one of the most common cancers among women, could soon benefit from a new therapeutic approach. A new ...

Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, it is still a bit surprising, since the pharmaceutical giant is one of the ...

Major medical initiatives to bolster Saudi Arabia’s healthcare sector have been unveiled this week, including a state-of-the-art oncology center and a huge ...

Donald Waugh, known to Grange Hill fans as Hughsey, his tenure ending in 1980, faced a harrowing journey of alcoholism and homelessness. Triumphantly overcoming his struggles, he now focuses on aiding ...

Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.